China Pharma Holdings Free Cash Flow 2010-2023 | CPHI
China Pharma Holdings free cash flow from 2010 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| China Pharma Holdings Annual Free Cash Flow |
| 2023 |
-0.71 |
| 2022 |
-0.81 |
| 2021 |
-0.69 |
| 2020 |
-0.91 |
| 2019 |
0.47 |
| 2018 |
1.83 |
| 2017 |
0.71 |
| 2016 |
2.70 |
| 2015 |
2.67 |
| 2014 |
-1.27 |
| 2013 |
-10.20 |
| 2012 |
1.87 |
| 2011 |
4.89 |
| 2010 |
7.72 |
| 2009 |
10.53 |
| China Pharma Holdings Quarterly Free Cash Flow |
| 2023-12-31 |
-0.71 |
| 2023-09-30 |
-0.68 |
| 2023-06-30 |
-1.62 |
| 2023-03-31 |
-1.41 |
| 2022-12-31 |
-0.81 |
| 2022-09-30 |
-1.42 |
| 2022-06-30 |
-1.39 |
| 2022-03-31 |
-0.88 |
| 2021-12-31 |
-0.69 |
| 2021-09-30 |
-0.48 |
| 2021-06-30 |
0.38 |
| 2021-03-31 |
-0.28 |
| 2020-12-31 |
-0.91 |
| 2020-09-30 |
-1.48 |
| 2020-06-30 |
-0.99 |
| 2020-03-31 |
-0.59 |
| 2019-12-31 |
0.47 |
| 2019-09-30 |
0.55 |
| 2019-06-30 |
0.08 |
| 2019-03-31 |
-0.31 |
| 2018-12-31 |
1.83 |
| 2018-09-30 |
0.97 |
| 2018-06-30 |
0.09 |
| 2018-03-31 |
0.52 |
| 2017-12-31 |
0.71 |
| 2017-09-30 |
-0.16 |
| 2017-06-30 |
-0.83 |
| 2017-03-31 |
-0.02 |
| 2016-12-31 |
2.70 |
| 2016-09-30 |
1.34 |
| 2016-06-30 |
0.49 |
| 2016-03-31 |
1.26 |
| 2015-12-31 |
2.67 |
| 2015-09-30 |
0.34 |
| 2015-06-30 |
-0.78 |
| 2015-03-31 |
-0.05 |
| 2014-12-31 |
-1.27 |
| 2014-09-30 |
-2.29 |
| 2014-06-30 |
-2.13 |
| 2014-03-31 |
-1.26 |
| 2013-12-31 |
-10.20 |
| 2013-09-30 |
-5.57 |
| 2013-06-30 |
3.01 |
| 2013-03-31 |
0.70 |
| 2012-12-31 |
1.87 |
| 2012-09-30 |
1.87 |
| 2012-06-30 |
1.83 |
| 2012-03-31 |
-0.40 |
| 2011-12-31 |
4.89 |
| 2011-09-30 |
5.13 |
| 2011-06-30 |
3.38 |
| 2011-03-31 |
1.33 |
| 2010-12-31 |
7.72 |
| 2010-09-30 |
5.84 |
| 2010-06-30 |
3.17 |
| 2010-03-31 |
1.07 |
| 2009-12-31 |
10.53 |
| 2009-09-30 |
6.13 |
| 2009-06-30 |
2.83 |
| 2009-03-31 |
0.59 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.005B |
$0.007B |
|
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
|
